1st Quarter - Report

GRASSROOTS POLITICAL CONSULTING LLC for REVIVE THERAPEUTICS INC.

Firm
Client
Income
$15,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocating for assistance w/Phase 3 trial for Bucillamine, educating Members of Congress, BARDA/HHS and NIH regarding Bucillamine as a repurposed drug for COVID19.

Foreign entity interest: Canadian company listed on CSE

LobbyistCovered position, as disclosed
DANIEL FARACI —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
REVIVE THERAPEUTICS Canada Canada 100.0% $15,000

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.